Advertisement
Advertisement
July 18, 2018
Ra Medical Systems Files for Proposed Initial Public Offering
July 18, 2018—Ra Medical Systems, Inc. announced that it has filed a registration with the United States Securities and Exchange Commission relating to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Ra Medical Systems has applied to list its common stock on the New York Stock Exchange under the ticker symbol: RMED.
In May 2017, the company announced FDA market clearance for the DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) atherectomy system with catheter for the treatment of peripheral artery disease. In October 2016, the company announced that the DABRA system was approved in Europe.
The offering will be made only by means of a prospectus, which will be available from Piper Jaffray & Co. in Minneapolis, Minnesota, and Cantor Fitzgerald & Co. in New York, New York.
Advertisement
Advertisement
